Click for best price
Celiac Drugs Market Size, Share 2022
Market Analysis and Insights: Global Celiac Drugs Market
The global Celiac Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Celiac Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Celiac Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Celiac Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Celiac Drugs market.
Global Celiac Drugs Scope and Market Size
Celiac Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Celiac Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Celiac Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
First Line Of Treatment
Second Line Of Treatment
Segment by Application
Men
Women
Children
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Celiac Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Celiac Drugs, with price, sales, revenue, and global market share of Celiac Drugs from 2019 to 2022.
Chapter 3, the Celiac Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celiac Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Celiac Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Celiac Drugs.
Chapter 13, 14, and 15, to describe Celiac Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Celiac Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Celiac Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
126 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Celiac Drugs Product Introduction
1.2 Global Celiac Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Celiac Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Celiac Drugs Sales in Volume for the Year 2017-2028
1.3 United States Celiac Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Celiac Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Celiac Drugs Sales in Volume for the Year 2017-2028
1.4 Celiac Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Celiac Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Celiac Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Celiac Drugs Market Dynamics
1.5.1 Celiac Drugs Industry Trends
1.5.2 Celiac Drugs Market Drivers
1.5.3 Celiac Drugs Market Challenges
1.5.4 Celiac Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Celiac Drugs Market Segment by Type
2.1.1 First Line Of Treatment
2.1.2 Second Line Of Treatment
2.2 Global Celiac Drugs Market Size by Type
2.2.1 Global Celiac Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Celiac Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Celiac Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Celiac Drugs Market Size by Type
2.3.1 United States Celiac Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Celiac Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Celiac Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Celiac Drugs Market Segment by Application
3.1.1 Men
3.1.2 Women
3.1.3 Children
3.2 Global Celiac Drugs Market Size by Application
3.2.1 Global Celiac Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Celiac Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Celiac Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Celiac Drugs Market Size by Application
3.3.1 United States Celiac Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Celiac Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Celiac Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Celiac Drugs Competitor Landscape by Company
4.1 Global Celiac Drugs Market Size by Company
4.1.1 Top Global Celiac Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Celiac Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Celiac Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Celiac Drugs Price by Manufacturer (2017-2022)
4.2 Global Celiac Drugs Concentration Ratio (CR)
4.2.1 Celiac Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Celiac Drugs in 2021
4.2.3 Global Celiac Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Celiac Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Celiac Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Celiac Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Celiac Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Celiac Drugs Market Size by Company
4.5.1 Top Celiac Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Celiac Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Celiac Drugs Sales by Players (2020, 2021 & 2022)
5 Global Celiac Drugs Market Size by Region
5.1 Global Celiac Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Celiac Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Celiac Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Celiac Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Celiac Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Celiac Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Celiac Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Celiac Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Celiac Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Celiac Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Celiac Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Celiac Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Celiac Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Celiac Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Celiac Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Celiac Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Celiac Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 ADMA Biologics
7.1.1 ADMA Biologics Corporation Information
7.1.2 ADMA Biologics Description and Business Overview
7.1.3 ADMA Biologics Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 ADMA Biologics Celiac Drugs Products Offered
7.1.5 ADMA Biologics Recent Development
7.2 Amgen
7.2.1 Amgen Corporation Information
7.2.2 Amgen Description and Business Overview
7.2.3 Amgen Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Amgen Celiac Drugs Products Offered
7.2.5 Amgen Recent Development
7.3 Anthera Pharmaceuticals
7.3.1 Anthera Pharmaceuticals Corporation Information
7.3.2 Anthera Pharmaceuticals Description and Business Overview
7.3.3 Anthera Pharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Anthera Pharmaceuticals Celiac Drugs Products Offered
7.3.5 Anthera Pharmaceuticals Recent Development
7.4 Bayer
7.4.1 Bayer Corporation Information
7.4.2 Bayer Description and Business Overview
7.4.3 Bayer Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Bayer Celiac Drugs Products Offered
7.4.5 Bayer Recent Development
7.5 Biogen
7.5.1 Biogen Corporation Information
7.5.2 Biogen Description and Business Overview
7.5.3 Biogen Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Biogen Celiac Drugs Products Offered
7.5.5 Biogen Recent Development
7.6 BioLineRx
7.6.1 BioLineRx Corporation Information
7.6.2 BioLineRx Description and Business Overview
7.6.3 BioLineRx Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 BioLineRx Celiac Drugs Products Offered
7.6.5 BioLineRx Recent Development
7.7 Biotest
7.7.1 Biotest Corporation Information
7.7.2 Biotest Description and Business Overview
7.7.3 Biotest Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Biotest Celiac Drugs Products Offered
7.7.5 Biotest Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporation Information
7.8.2 Bristol-Myers Squibb Description and Business Overview
7.8.3 Bristol-Myers Squibb Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bristol-Myers Squibb Celiac Drugs Products Offered
7.8.5 Bristol-Myers Squibb Recent Development
7.9 Celgene
7.9.1 Celgene Corporation Information
7.9.2 Celgene Description and Business Overview
7.9.3 Celgene Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Celgene Celiac Drugs Products Offered
7.9.5 Celgene Recent Development
7.10 Celimmune
7.10.1 Celimmune Corporation Information
7.10.2 Celimmune Description and Business Overview
7.10.3 Celimmune Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Celimmune Celiac Drugs Products Offered
7.10.5 Celimmune Recent Development
7.11 F Hoffmann-La Roche
7.11.1 F Hoffmann-La Roche Corporation Information
7.11.2 F Hoffmann-La Roche Description and Business Overview
7.11.3 F Hoffmann-La Roche Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 F Hoffmann-La Roche Celiac Drugs Products Offered
7.11.5 F Hoffmann-La Roche Recent Development
7.12 ImmunogenX
7.12.1 ImmunogenX Corporation Information
7.12.2 ImmunogenX Description and Business Overview
7.12.3 ImmunogenX Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 ImmunogenX Products Offered
7.12.5 ImmunogenX Recent Development
7.13 Immunomedics
7.13.1 Immunomedics Corporation Information
7.13.2 Immunomedics Description and Business Overview
7.13.3 Immunomedics Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Immunomedics Products Offered
7.13.5 Immunomedics Recent Development
7.14 ImmusanT
7.14.1 ImmusanT Corporation Information
7.14.2 ImmusanT Description and Business Overview
7.14.3 ImmusanT Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 ImmusanT Products Offered
7.14.5 ImmusanT Recent Development
7.15 Innovate Biopharmaceuticals
7.15.1 Innovate Biopharmaceuticals Corporation Information
7.15.2 Innovate Biopharmaceuticals Description and Business Overview
7.15.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Innovate Biopharmaceuticals Products Offered
7.15.5 Innovate Biopharmaceuticals Recent Development
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Corporation Information
7.16.2 Johnson & Johnson Description and Business Overview
7.16.3 Johnson & Johnson Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Johnson & Johnson Products Offered
7.16.5 Johnson & Johnson Recent Development
7.17 Kedrion Biopharma
7.17.1 Kedrion Biopharma Corporation Information
7.17.2 Kedrion Biopharma Description and Business Overview
7.17.3 Kedrion Biopharma Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Kedrion Biopharma Products Offered
7.17.5 Kedrion Biopharma Recent Development
7.18 LFB Group
7.18.1 LFB Group Corporation Information
7.18.2 LFB Group Description and Business Overview
7.18.3 LFB Group Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.18.4 LFB Group Products Offered
7.18.5 LFB Group Recent Development
7.19 Merck
7.19.1 Merck Corporation Information
7.19.2 Merck Description and Business Overview
7.19.3 Merck Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Merck Products Offered
7.19.5 Merck Recent Development
7.20 Novartis
7.20.1 Novartis Corporation Information
7.20.2 Novartis Description and Business Overview
7.20.3 Novartis Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Novartis Products Offered
7.20.5 Novartis Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Celiac Drugs Industry Chain Analysis
8.2 Celiac Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Celiac Drugs Distributors
8.3 Celiac Drugs Production Mode & Process
8.4 Celiac Drugs Sales and Marketing
8.4.1 Celiac Drugs Sales Channels
8.4.2 Celiac Drugs Distributors
8.5 Celiac Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Celiac Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Celiac Drugs Market Trends
Table 3. Celiac Drugs Market Drivers
Table 4. Celiac Drugs Market Challenges
Table 5. Celiac Drugs Market Restraints
Table 6. Global Celiac Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Celiac Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Celiac Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Celiac Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Celiac Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Celiac Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Celiac Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Celiac Drugs Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Celiac Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Celiac Drugs Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Celiac Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Celiac Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Drugs as of 2021)
Table 18. Top Players of Celiac Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Celiac Drugs Product Type
Table 20. Date of International Manufacturers Enter into Celiac Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Celiac Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Celiac Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Celiac Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Celiac Drugs Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Celiac Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Celiac Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Celiac Drugs Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Celiac Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Celiac Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Celiac Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Celiac Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Celiac Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Celiac Drugs Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Celiac Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Celiac Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Celiac Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Celiac Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Celiac Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Celiac Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Celiac Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. ADMA Biologics Corporation Information
Table 43. ADMA Biologics Description and Business Overview
Table 44. ADMA Biologics Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. ADMA Biologics Celiac Drugs Product
Table 46. ADMA Biologics Recent Development
Table 47. Amgen Corporation Information
Table 48. Amgen Description and Business Overview
Table 49. Amgen Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Amgen Product
Table 51. Amgen Recent Development
Table 52. Anthera Pharmaceuticals Corporation Information
Table 53. Anthera Pharmaceuticals Description and Business Overview
Table 54. Anthera Pharmaceuticals Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Anthera Pharmaceuticals Product
Table 56. Anthera Pharmaceuticals Recent Development
Table 57. Bayer Corporation Information
Table 58. Bayer Description and Business Overview
Table 59. Bayer Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Bayer Product
Table 61. Bayer Recent Development
Table 62. Biogen Corporation Information
Table 63. Biogen Description and Business Overview
Table 64. Biogen Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Biogen Product
Table 66. Biogen Recent Development
Table 67. BioLineRx Corporation Information
Table 68. BioLineRx Description and Business Overview
Table 69. BioLineRx Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. BioLineRx Product
Table 71. BioLineRx Recent Development
Table 72. Biotest Corporation Information
Table 73. Biotest Description and Business Overview
Table 74. Biotest Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Biotest Product
Table 76. Biotest Recent Development
Table 77. Bristol-Myers Squibb Corporation Information
Table 78. Bristol-Myers Squibb Description and Business Overview
Table 79. Bristol-Myers Squibb Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Bristol-Myers Squibb Product
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Celgene Corporation Information
Table 83. Celgene Description and Business Overview
Table 84. Celgene Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Celgene Product
Table 86. Celgene Recent Development
Table 87. Celimmune Corporation Information
Table 88. Celimmune Description and Business Overview
Table 89. Celimmune Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Celimmune Product
Table 91. Celimmune Recent Development
Table 92. F Hoffmann-La Roche Corporation Information
Table 93. F Hoffmann-La Roche Description and Business Overview
Table 94. F Hoffmann-La Roche Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. F Hoffmann-La Roche Product
Table 96. F Hoffmann-La Roche Recent Development
Table 97. ImmunogenX Corporation Information
Table 98. ImmunogenX Description and Business Overview
Table 99. ImmunogenX Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. ImmunogenX Product
Table 101. ImmunogenX Recent Development
Table 102. Immunomedics Corporation Information
Table 103. Immunomedics Description and Business Overview
Table 104. Immunomedics Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. Immunomedics Product
Table 106. Immunomedics Recent Development
Table 107. ImmusanT Corporation Information
Table 108. ImmusanT Description and Business Overview
Table 109. ImmusanT Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. ImmusanT Product
Table 111. ImmusanT Recent Development
Table 112. Innovate Biopharmaceuticals Corporation Information
Table 113. Innovate Biopharmaceuticals Description and Business Overview
Table 114. Innovate Biopharmaceuticals Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. Innovate Biopharmaceuticals Product
Table 116. Innovate Biopharmaceuticals Recent Development
Table 117. Johnson & Johnson Corporation Information
Table 118. Johnson & Johnson Description and Business Overview
Table 119. Johnson & Johnson Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. Johnson & Johnson Product
Table 121. Johnson & Johnson Recent Development
Table 122. Kedrion Biopharma Corporation Information
Table 123. Kedrion Biopharma Description and Business Overview
Table 124. Kedrion Biopharma Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Kedrion Biopharma Product
Table 126. Kedrion Biopharma Recent Development
Table 127. LFB Group Corporation Information
Table 128. LFB Group Description and Business Overview
Table 129. LFB Group Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. LFB Group Product
Table 131. LFB Group Recent Development
Table 132. Merck Corporation Information
Table 133. Merck Description and Business Overview
Table 134. Merck Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Merck Product
Table 136. Merck Recent Development
Table 137. Novartis Corporation Information
Table 138. Novartis Description and Business Overview
Table 139. Novartis Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. Novartis Product
Table 141. Novartis Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Celiac Drugs Customers List
Table 145. Celiac Drugs Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Celiac Drugs Product Picture
Figure 2. Global Celiac Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Celiac Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Celiac Drugs Sales 2017-2028 (K MT)
Figure 5. United States Celiac Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Celiac Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Celiac Drugs Sales 2017-2028 (K MT)
Figure 8. United States Celiac Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Celiac Drugs Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Celiac Drugs Report Years Considered
Figure 11. Product Picture of First Line Of Treatment
Figure 12. Product Picture of Second Line Of Treatment
Figure 13. Global Celiac Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Celiac Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Celiac Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Celiac Drugs Sales by Type (2017-2028) & (K MT)
Figure 17. Global Celiac Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Celiac Drugs Price by Type (2017-2028) & (USD/MT)
Figure 19. United States Celiac Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Celiac Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Celiac Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Celiac Drugs Sales by Type (2017-2028) & (K MT)
Figure 23. United States Celiac Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Celiac Drugs Price by Type (2017-2028) & (USD/MT)
Figure 25. Product Picture of Men
Figure 26. Product Picture of Women
Figure 27. Product Picture of Children
Figure 28. Global Celiac Drugs Market Share by Application in 2022 & 2028
Figure 29. Global Celiac Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Celiac Drugs Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Celiac Drugs Sales by Application (2017-2028) & (K MT)
Figure 32. Global Celiac Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Celiac Drugs Price by Application (2017-2028) & (USD/MT)
Figure 34. United States Celiac Drugs Market Share by Application in 2022 & 2028
Figure 35. United States Celiac Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Celiac Drugs Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Celiac Drugs Sales by Application (2017-2028) & (K MT)
Figure 38. United States Celiac Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Celiac Drugs Price by Application (2017-2028) & (USD/MT)
Figure 40. North America Celiac Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 41. North America Celiac Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Celiac Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 45. Europe Celiac Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Celiac Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 52. Asia-Pacific Celiac Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Celiac Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 64. Latin America Celiac Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Celiac Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 69. Middle East & Africa Celiac Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Celiac Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Celiac Drugs Value Chain
Figure 74. Celiac Drugs Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
